Seeing Is Believing
with an average price target of $52.22. This is a potential upside of $29.21 (126.94%) from yesterday's end of day stock price of $23.01.
Harpoon Therapeutics's activity chart (see below) currently has 69 price targets and 58 ratings on display.
Analysts average stock forecasts to be materialized ratio is 43.64% with an average time for these price targets to be met of 208.27 days.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 26-Feb-2024. First documented stock forecast 05-Mar-2019.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 26-Feb-2024
$13
$-10.01 (-43.50%)
$13
1 years 10 months 13 days ago
(26-Feb-2024)
3/9 (33.33%)
$-9.93 (-43.31%)
216
Hold
Since 14-Dec-2022
$23
$-0.01 (-0.04%)
$20
1 years 11 months 30 days ago
(09-Jan-2024)
4/5 (80%)
$0.64 (2.86%)
215
Hold
Since 08-Jan-2024
$23
$-0.01 (-0.04%)
$12
2 years ago
(08-Jan-2024)
3/4 (75%)
$0.64 (2.86%)
43
Buy
Since 03-Feb-2020
$12
$-11.01 (-47.85%)
2 years 26 days ago
(13-Dec-2023)
1/2 (50%)
$2.54 (26.85%)
9
Buy
Since 10-May-2021
$70
2 years 9 months 8 days ago
(31-Mar-2023)
0/5 (0%)
$50 (250.00%)
What is HARP (Harpoon Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on HARP (Harpoon Therapeutics) with a proven track record?
Which analyst has the most public recommendations on HARP (Harpoon Therapeutics)?
Which analyst is the currently most bullish on HARP (Harpoon Therapeutics)?
Which analyst is the currently most reserved on HARP (Harpoon Therapeutics)?